control group:Lianggan Qingxin Jiangya capsule placebo
Sponsors
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Conditions
Essential Hypertension
Early Phase 1
A randomized, double-blind, placebo-controlled, multicenter clinical study of Lianggan Qingxin Jiangya capsule in the treatment of grade 1 hypertension with liver fire syndrome
Active, not recruitingITMCTR2000003176
Start: 2020-04-20Updated: 2023-02-20
A randomized, double-blind, placebo-controlled, multicenter clinical study of Lianggan Qingxin Jiangya capsule in the treatment of grade 1 hypertension with liver fire syndrome
Active, not recruitingChiCTR2000031573
Start: 2020-04-20Updated: 2020-04-06